Innovation Pharmaceuticals Completes Gastric Fluid Testing of Brilacidin Supporting Development of an Oral Dosage Form to Treat Inflammatory Bowel Disease

    NEXT STORY
    Generex Announces Investor Conference Call-in Details; Management to Provide Update on Initiatives & Strategic Plans
    PREV STORY
    Data Supporting the Cardiovascular Safety of VIVUS’ Qsymia® Published in The Journal of Clinical Endocrinology & Metabolism
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    HTG Molecular Diagnostics Reports Second Quarter 2018 Results

    Revenue increased 179% and 190%, respectively, compared to the three and six-month periods in ...

    author_avatar
    NASDAQ Market News

    Kaleido Biosciences Announces CEO Leadership Transition

    author_avatar
    NASDAQ Market News

    Precipio Enters India Liquid Biopsy Market with Adoption by Leading Laboratory

    NEW HAVEN, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostic company Precipio, Inc. ...

    author_avatar
    NASDAQ Market News